Comparative arrhythmia patterns among patients on tyrosine kinase inhibitors.
Chen WeiMuhammad FazalAlexander LohRidhima KapoorSofia Elena GomezShayena ShahAlbert J RogersSanjiv M NarayanPaul J WangRonald M WittelesAlexander C PerinoPaul ChengJune-Wha RheeTina BaykanerPublished in: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2023)
In this large retrospective analysis of patients with hematologic malignancies, patients receiving ibrutinib had a higher prevalence of atrial and ventricular arrhythmias compared to those receiving other TKI, with a higher rate of treatment interruption due to arrhythmias.